Stem Cell Therapy for Myocardial Infarction Recovery: Advances, Challenges, and Future Directions
Myocardial infarction (MI) is a leading cause of morbidity worldwide, resulting from ischemic damage and necrosis to cardiomyocytes. While the standard treatment regimen for MI can be successful in restoring coronary perfusion, it typically does not resolve myocardial damage, which can leave patient...
Saved in:
| Main Authors: | Nicholas T. Le, Matthew W. Dunleavy, William Zhou, Sumrithbir S. Bhatia, Rebecca D. Kumar, Suyin T. Woo, Gonzalo Ramirez-Pulido, Kaushik S. Ramakrishnan, Ahmed H. El-Hashash |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/5/1209 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial
by: Jerome Roncalli, et al.
Published: (2025-04-01) -
Heart to heart: grafting cardiosphere‐derived cells augments cardiac self‐repair by both myocytes and stem cells
by: Jose A. Palacios, et al.
Published: (2013-02-01) -
Heart stem cells: fact or fantasy?
by: E. V. Parfenova
Published: (2019-11-01) -
Heart stem cells: hope or myth?
by: P. M. Dokshin, et al.
Published: (2021-11-01) -
THROMBOLYTIC THERAPY IN PATIENTS WITH MYOCARDIAL INFARCTION
by: G. P. Ishmurzin, et al.
Published: (2010-12-01)